1. Home
  2. YALA vs ABCL Comparison

YALA vs ABCL Comparison

Compare YALA & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yalla Group Limited each representing one

YALA

Yalla Group Limited each representing one

HOLD

Current Price

$6.56

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$3.41

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YALA
ABCL
Founded
2016
2012
Country
United Arab Emirates
Canada
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
YALA
ABCL
Price
$6.56
$3.41
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.75
AVG Volume (30 Days)
323.6K
2.4M
Earning Date
05-18-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.91
EPS
N/A
N/A
Revenue
N/A
$75,128,000.00
Revenue This Year
$16.40
N/A
Revenue Next Year
$7.13
$25.44
P/E Ratio
$8.76
N/A
Revenue Growth
N/A
160.56
52 Week Low
$5.13
$1.94
52 Week High
$9.29
$6.52

Technical Indicators

Market Signals
Indicator
YALA
ABCL
Relative Strength Index (RSI) 52.76 49.10
Support Level $6.04 $3.37
Resistance Level $7.32 $3.84
Average True Range (ATR) 0.23 0.16
MACD 0.06 -0.00
Stochastic Oscillator 77.56 43.33

Price Performance

Historical Comparison
YALA
ABCL

About YALA Yalla Group Limited each representing one

Yalla Group Ltd is a MENA-based online social networking and gaming company. It operates two flagship mobile applications, Yalla, a voice-centric group chat platform, and Yalla Ludo, a casual gaming application featuring online versions of board games popular in MENA, with in-game voice chat and localized majlis functions. The Group has one operating segment, which is the social networking and entertainment platform.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: